跳至主要内容
临床试验/DRKS00019938
DRKS00019938已完成不适用

on-interventional observational study on the use of autologous platelet-rich fibrin membranes in the therapy of antiresorbiva-associated necrosis of the jaw - APANK

niversitätsklinikum Schleswig-Holstein (UKSH)0 个研究点目标入组 52 人开始时间: 2020年1月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Patients undergoing MRONJ in stage 1, 2 or 3 according to the criteria of AAOMS
  • - Previous or current use of bisphosphonates or RANK-L inhibitors subcutaneously or intravenously in malignant disease
  • - Peri- and posttherapeutic intravenous high-dose antibiotics until the 5th day postoperative using Unacid 3g i.v. 1-1-1
  • - Peri- and post-therapeutic diet by means of nasogastric probe food

排除标准

  • - positive history of radiation in the head and neck area
  • - MRONJ Diagnosis without Clinical Exposure of Exposed Jaw Bone (Stage 0)
  • - microvascular reconstruction in the head and neck area
  • - Patients with renovations under local anesthesia
  • - Hemorrhagic diathesis or thrombocytopenia <150,000 / µl

研究者

发起方
niversitätsklinikum Schleswig-Holstein (UKSH)

相似试验